HCN2 Protein - Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2

HCN2 Protein - Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2

Introduction

Hcn2 Protein Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@hcna]
title: HCN2 Protein [@therapeutic]
description: Hyperpolarization-activated cyclic nucleotide-gated channel 2 [@disease]

--- [@clinical]

HCN2 Protein - Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2

Introduction

Hcn2 Protein Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@hcna]
title: HCN2 Protein [@therapeutic]
description: Hyperpolarization-activated cyclic nucleotide-gated channel 2 [@disease]

--- [@clinical]

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">HCN2 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2</td></tr>
<tr><td><strong>Gene</strong></td><td>[HCN2](/genes/hcn2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UQB8" target="_blank">Q9UQB8</a></td></tr>
<tr><td><strong>PDB Structure</strong></td><td>1QDR, 5U6O</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~95 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane (neuronal dendrites)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>HCN channel family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/arm" style="color:#ef9a9a">ARM</a>, <a href="/wiki/absence-seizures" style="color:#ef9a9a">Absence Seizures</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">57 edges</a></td>
</tr>
</table>
</div>

Overview

HCN2 encodes the Hyperpolarization-activated Cyclic Nucleotide-gated channel 2, a voltage-gated cation channel that generates the hyperpolarization-activated current (Ih). These channels are crucial for neuronal pacemaking, synaptic integration, and resonance properties.

Structure

HCN channels are voltage-gated cation channels with unique gating properties.

Domain Architecture

• Six Transmembrane Segments (S1-S6): Voltage-sensing and pore-forming domains
• Cyclic Nucleotide-Binding Domain (CNBD): Located in the C-terminus, binds cAMP
• S4 Helix: Voltage sensor with positively charged residues
• P-loop Region: Forms the channel pore between S5 and S6

Structural Features

• Tetrameric Assembly: Functional channels are tetramers
• cAMP Binding: Direct binding to CNBD modulates gating
• Voltage Dependence: Activated by hyperpolarization below -50 mV

Normal Function

Ion Permeability

HCN channels pass a mixed Na+/K+ current:

• Permeability Ratio: PN:PK ≈ 1:4
• Reversal Potential: Approximately -30 mV
• Current (Ih): Depolarizing current activated by hyperpolarization

Molecular Functions

• Pacemaker Activity: Generates rhythmic depolarization in spontaneously active neurons
• Resting Potential: Modulates resting membrane potential
• Synaptic Integration: Affects dendritic integration and temporal processing
• Resonance: Enables frequency-selective neuronal responses

Cellular Roles

• Thalamocortical [Neurons](/entities/neurons): Ih supports burst firing and sleep spindles
• Cardiac Pacemaking: Critical for sinoatrial node function
• Hippocampal Neurons: Modulates place cell firing and spatial memory

Role in Disease

Epilepsy

• Thalamic Dysfunction: Altered HCN2 in thalamocortical neurons promotes hyperexcitability
• Absence Seizures: Reduced Ih contributes to spike-wave discharges
• Therapeutic Target: HCN blockers (ivabradine) being investigated

Cardiac Arrhythmias

• Sinus Node Dysfunction: HCN2 is essential for cardiac pacemaking
• Bradycardia: Reduced HCN2 function causes slow heart rate
• Therapeutic: Ivabradine used to treat inappropriate sinus tachycardia

Parkinson's Disease

• Basal Ganglia: Altered HCN channel function in PD models
• Motor Symptoms: HCN modulators may improve symptoms
• L-DOPA Dyskinesia: Role under investigation

Neuropathic Pain

• Sensory Neurons: HCN2 in nociceptors contributes to pain signaling
• Chronic Pain: HCN blockers may have analgesic potential

Therapeutic Targeting

Drug Development

Pharmacological Agents

• Ivabradine: Specific HCN channel blocker
• ZD7288: Experimental HCN blocker used in research
• Lamotrigine: Anticonvulsant with HCN-blocking properties

Key Publications

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [HCN2 Gene](/proteins/hcn2-protein)
• [Thalamus](/brain-regions/thalamus)
• [Ion Channelopathies](/mechanisms/ion-channelopathies)
• [Cardiac Arrhythmias](/diseases/cardiac-arrhythmias)

External Links

• [UniProt: HCN2 (Q9UQB8)](https://www.uniprot.org/uniprot/Q9UQB8)
• [PDB: HCN2](https://www.rcsb.org/structure/1QDR)
• [NCBI Protein: HCN2](https://www.ncbi.nlm.nih.gov/protein/NP_001191.2)

Background

The study of Hcn2 Protein Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References